Haselmeier Overview
- Year Founded
-
1920
- Status
-
Acquired/Merged
- Employees
-
230
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
- Investments
-
1
Haselmeier General Information
Description
Manufacturer of drug delivery systems used for fertility drugs and anti-diabetes drugs intended to improve the efficiency and efficacy of therapy. The company offers assembly, labeling, and packaging services that empower patients and make a difference across a range of care areas, thereby supporting patients' approach to type 2 diabetes treatment.
Contact Information
Website
www.haselmeier.com(Operating Subsidiary)
Corporate Office
- Schelmenwasenstraße 14
- 70567 Stuttgart
- Germany
Corporate Office
- Schelmenwasenstraße 14
- 70567 Stuttgart
- Germany
Haselmeier Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Haselmeier Comparisons
Industry
Financing
Details
Haselmeier Competitors (10)
One of Haselmeier’s 10 competitors is Enable Injections, a Venture Capital-Backed company based in Cincinnati, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Enable Injections | Venture Capital-Backed | Cincinnati, OH | ||||
| CeQur Simplicity | Venture Capital-Backed | Greenville, SC | ||||
| Nemera | Private Equity-Backed | Lyon, France | ||||
| PharmaJet | Venture Capital-Backed | Golden, CO | ||||
| NanoPass Technologies | Venture Capital-Backed | Nes Ziona, Israel |
Haselmeier Patents
Haselmeier Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220323685-A1 | Drug delivery device | Inactive | 07-Apr-2021 | ||
| US-20220323686-A1 | Drug delivery device | Inactive | 07-Apr-2021 | ||
| WO-2021099415-A1 | Drug delivery device | Inactive | 18-Nov-2019 | ||
| US-20240066227-A1 | Keyed connectors for medicament delivery devices | Pending | 08-Oct-2019 | ||
| WO-2021069284-A1 | Keyed connectors for medicament delivery devices | Inactive | 08-Oct-2019 | A61M5/24 |
Haselmeier Signals
Haselmeier Investments (1)
Haselmeier’s most recent deal was a Later Stage VC with Common Sensing for . The deal was made on 29-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Common Sensing | 29-Mar-2018 | Later Stage VC | Monitoring Equipment |
Haselmeier Exits (1)
Haselmeier’s most recent exit was on 29-Mar-2018 from Common Sensing. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Common Sensing | 29-Mar-2018 | Completed |
|
Haselmeier FAQs
-
When was Haselmeier founded?
Haselmeier was founded in 1920.
-
Where is Haselmeier headquartered?
Haselmeier is headquartered in Stuttgart, Germany.
-
What is the size of Haselmeier?
Haselmeier has 230 total employees.
-
What industry is Haselmeier in?
Haselmeier’s primary industry is Other Commercial Products.
-
Is Haselmeier a private or public company?
Haselmeier is a Private company.
-
What is the current valuation of Haselmeier?
The current valuation of Haselmeier is .
-
What is Haselmeier’s current revenue?
The current revenue for Haselmeier is .
-
Who are Haselmeier’s competitors?
Enable Injections, CeQur Simplicity, Nemera, PharmaJet, and NanoPass Technologies are some of the 10 competitors of Haselmeier.
-
When was Haselmeier acquired?
Haselmeier was acquired on 01-Oct-2020.
-
Who acquired Haselmeier?
Haselmeier was acquired by Sulzer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process